U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921512) titled 'TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms' on March 31.
Brief Summary: This 12-week single-arm clinical trial investigates the effects of Traditional Chinese Medicine (TCM) Daoyin exercise on anxiety and depression symptoms in 20 participants, followed by a 12-week observational follow-up period.
The primary outcome is the change in Hamilton Anxiety Rating Scale (HAMA-14) and Hamilton Depression Rating Scale (HAMD-17) scores at 12 weeks. A secondary outcome will assess these scores at 24 weeks to evaluate sustained effects. Additional secondary outcomes include the Depression, Anxiety, and ...